| Current Price | $1.32 | Mkt Cap | $31.3M |
|---|---|---|---|
| Open | $1.31 | P/E Ratio | -0.28 |
| Prev. Close | $1.32 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $1.30 - $1.37 | Volume | 14,187 |
| 52-Wk Range | $0.93 - $10.75 | Avg. Daily Vol. | 58,590 |
Impel NeuroPharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapies for patients suffering from central nervous system disease in the United States.
| Current Price | $1.32 | Mkt Cap | $31.3M |
|---|---|---|---|
| Open | $1.31 | P/E Ratio | -0.28 |
| Prev. Close | $1.32 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $1.30 - $1.37 | Volume | 14,187 |
| 52-Wk Range | $0.93 - $10.75 | Avg. Daily Vol. | 58,590 |
The best Bull and Bear pitches based on recency and number of recommendations.
Read the most recent pitches from players about IMPL.
Find the members with the highest scoring picks in IMPL.
HDTVBG (< 20) Score: +17.00
The Score Leader is the player with the highest score across all their picks in IMPL.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
|
ababrmon | 66.86 | 4/18/2022 |
|
5Y | $6.57 | -79.59% | -2.19% | -77.40 | 0 Comment |
| SWRider | 62.48 | 4/18/2022 |
|
5Y | $7.36 | -81.79% | -1.96% | -79.83 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
